NYSE:JNJPharmaceuticals
Drug Pricing Pressure Puts GSK And Global Pharma Stocks In Focus
Global pharma is back in the political spotlight, as US pressure on drug prices abroad collides with European cost controls and fresh trade tensions. For investors, this mix of policy risk and pricing shifts could change how large pharmaceutical stocks are viewed, especially those with significant US and European exposure. This article looks at three large-cap global pharmaceutical companies from our screener that appear especially exposed to the latest headlines, and explains why some...